Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

ResMed Inc.

NYSE

Market Cap.

32.11B

Avg. Volume

1.1M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze ResMed Inc.!

Still processing it, give me a bit more time...

ResMed Inc. News

ResMed Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Instruments & Supplies
resmed.com

About ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

ResMed Inc. Earnings & Revenue

ResMed Inc. Financials

Table Compare

Compare RMD metrics with:

   

Earnings & Growth

RMD

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

RMD

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

RMD

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

RMD

None

Debt Ratio

--

--

Quick Ratio

--

--

 

ResMed Inc. Income

ResMed Inc. Balance Sheet

ResMed Inc. Cash Flow

ResMed Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioNeutral
Price/Earnings RatioBuy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

ResMed Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.92

Payment DateDividendFrequency
2024-06-130.48Quarterly
2024-03-140.48Quarterly
2023-12-140.48Quarterly
2023-09-210.48Quarterly
2023-06-150.44Quarterly

Historical Market Cap

Shares Outstanding

ResMed Inc. Executives

NameRole
Mr. Michael J. Farrell BE, MBA, SMChief Executive Officer & Chairman
Mr. Robert A. DouglasSpecial Advisor
Mr. Kaushik GhoshalChief Commercial Officer - SaaS
Mr. Brett A. SandercockChief Financial Officer
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScDFounder, Chair Emeritus & Director
NameRoleGenderDate of BirthPay
Mr. Michael J. Farrell BE, MBA, SMChief Executive Officer & ChairmanMale19722.87M
Mr. Robert A. DouglasSpecial AdvisorMale19601.91M
Mr. Kaushik GhoshalChief Commercial Officer - SaaSMale19691.11M
Mr. Brett A. SandercockChief Financial OfficerMale1967909.64K
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScDFounder, Chair Emeritus & Director1942430.21K

ResMed Inc. Insider Trades

Date15 May
NameFARRELL PETER C
RoleDirector
TransactionDisposed
TypeG-Gift
Shares68200
Date15 May
NameDe Witte Jan
RoleDirector
TransactionDisposed
TypeS-Sale
Shares360
Date8 May
NameSandercock Brett
RoleChief Financial Officer
TransactionAcquired
TypeM-Exempt
Shares12000
Date8 May
NameSandercock Brett
RoleChief Financial Officer
TransactionDisposed
TypeS-Sale
Shares13000
Date8 May
NameSandercock Brett
RoleChief Financial Officer
TransactionDisposed
TypeM-Exempt
Shares12000
DateNameRoleTransactionTypeShares
15 MayFARRELL PETER CDirectorDisposedG-Gift68200
15 MayDe Witte JanDirectorDisposedS-Sale360
8 MaySandercock BrettChief Financial OfficerAcquiredM-Exempt12000
8 MaySandercock BrettChief Financial OfficerDisposedS-Sale13000
8 MaySandercock BrettChief Financial OfficerDisposedM-Exempt12000

Discover More

Streamlined Academy

ResMed Inc.

NYSE

Market Cap.

32.11B

Avg. Volume

1.1M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

ResMed Inc. News

ResMed Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

ResMed Inc. Earnings & Revenue

ResMed Inc. Income

ResMed Inc. Balance Sheet

ResMed Inc. Cash Flow

ResMed Inc. Financials Over Time

ResMed Inc. Executives

NameRole
Mr. Michael J. Farrell BE, MBA, SMChief Executive Officer & Chairman
Mr. Robert A. DouglasSpecial Advisor
Mr. Kaushik GhoshalChief Commercial Officer - SaaS
Mr. Brett A. SandercockChief Financial Officer
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScDFounder, Chair Emeritus & Director
NameRoleGenderDate of BirthPay
Mr. Michael J. Farrell BE, MBA, SMChief Executive Officer & ChairmanMale19722.87M
Mr. Robert A. DouglasSpecial AdvisorMale19601.91M
Mr. Kaushik GhoshalChief Commercial Officer - SaaSMale19691.11M
Mr. Brett A. SandercockChief Financial OfficerMale1967909.64K
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScDFounder, Chair Emeritus & Director1942430.21K

ResMed Inc. Insider Trades

Date15 May
NameFARRELL PETER C
RoleDirector
TransactionDisposed
TypeG-Gift
Shares68200
Date15 May
NameDe Witte Jan
RoleDirector
TransactionDisposed
TypeS-Sale
Shares360
Date8 May
NameSandercock Brett
RoleChief Financial Officer
TransactionAcquired
TypeM-Exempt
Shares12000
Date8 May
NameSandercock Brett
RoleChief Financial Officer
TransactionDisposed
TypeS-Sale
Shares13000
Date8 May
NameSandercock Brett
RoleChief Financial Officer
TransactionDisposed
TypeM-Exempt
Shares12000
DateNameRoleTransactionTypeShares
15 MayFARRELL PETER CDirectorDisposedG-Gift68200
15 MayDe Witte JanDirectorDisposedS-Sale360
8 MaySandercock BrettChief Financial OfficerAcquiredM-Exempt12000
8 MaySandercock BrettChief Financial OfficerDisposedS-Sale13000
8 MaySandercock BrettChief Financial OfficerDisposedM-Exempt12000

Streamlined Academy

Website screenshot
HealthcareMedical - Instruments & Supplies
resmed.com

About ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze ResMed Inc.!

Still processing it, give me a bit more time...

ResMed Inc. Financials

Table Compare

Compare RMD metrics with:

   

Earnings & Growth

RMD

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

RMD

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

RMD

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

RMD

None

Debt Ratio

--

--

Quick Ratio

--

--

 

ResMed Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.92

Payment DateDividendFrequency
2024-06-130.48Quarterly
2024-03-140.48Quarterly
2023-12-140.48Quarterly
2023-09-210.48Quarterly
2023-06-150.44Quarterly

ResMed Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioNeutral
Price/Earnings RatioBuy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More